Overview
Patrik Palacka practices in Bratislava, Slovakia. Mr. Palacka is rated as an Advanced expert by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Testicular Cancer, Choriocarcinoma, Urothelial Cancer, Peripheral Neuropathy, and Orchiectomy.
His clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Peripheral Neuropathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ChoriocarcinomaMr. Palacka isDistinguished. Learn about Choriocarcinoma.
- Testicular CancerMr. Palacka isDistinguished. Learn about Testicular Cancer.
- Advanced
- OrchiectomyMr. Palacka isAdvanced. Learn about Orchiectomy.
- Peripheral NeuropathyMr. Palacka isAdvanced. Learn about Peripheral Neuropathy.
- Urothelial CancerMr. Palacka isAdvanced. Learn about Urothelial Cancer.
- Experienced
- AgranulocytosisMr. Palacka isExperienced. Learn about Agranulocytosis.
- Bladder CancerMr. Palacka isExperienced. Learn about Bladder Cancer.
- COVID-19Mr. Palacka isExperienced. Learn about COVID-19.
- Febrile NeutropeniaMr. Palacka isExperienced. Learn about Febrile Neutropenia.
- Heart TumorMr. Palacka isExperienced. Learn about Heart Tumor.
- Long Haul COVIDMr. Palacka isExperienced. Learn about Long Haul COVID.